Weekly feed

Week of Nov 8–14, 2026

12 curated updates · reviewed against primary sources

Archive
All Open for comment ONC/ASTP CMS HL7 FHIR HITRUST FDA
High CMS

CMS finalizes Medicare Drug Price Negotiation Program and Part D policies as required by Inflation Reduction Act

The rule codifies the negotiation program for selected drugs and updates Part D policies, directly affecting drug pricing and reimbursement under Medicare. The Centers for Medicare & Medicaid Services (CMS) has issued a final rule that implements and codifies the Medicare Drug Price Negotiation...

High CMS

CMS Finalizes CY 2027 Payment Policies Including Promoting Interoperability Program Updates

CMS's CY 2027 physician fee schedule final rule updates the Medicare Promoting Interoperability Program alongside broader payment and coverage changes affecting Part B services and value-based care initiatives. The Centers for Medicare & Medicaid Services (CMS) has issued a final rule...

High CMS

CMS Finalizes CY 2027 Home Health PPS Updates and Expands HHVBP Model Requirements

The rule updates payment rates, case-mix weights, and quality reporting while expanding value-based purchasing requirements to all home health agencies by 2029, impacting reimbursement and data reporting workflows. CMS issued a final rule updating the Medicare Home Health Prospective Payment...

High CMS

CMS advances plan to ban hospital use of third-party RPM providers despite opposition

Medicare's push to prohibit hospitals from contracting out remote patient monitoring services creates compliance challenges for health systems while delaying broader RPM policy reforms until 2029. The Centers for Medicare & Medicaid Services (CMS) has moved forward with a controversial initiative...

High CMS HHS 💬 Comments close in 53 days (Jan 4)

CMS Finalizes 2027 OPPS and ASC Payment Rules with Quality Updates and Prior Authorization Expansion

The rule sets payment rates for hospital outpatient and ambulatory surgical center services for CY 2027, updates quality reporting programs, expands prior authorization for botulinum toxin injections, and affirms AO deeming for EMTALA compliance. The Centers for Medicare & Medicaid Services (CMS)...

Notable FDA

FDA Classifies Wearable Vibration Device for Orthopedic Use as Class II Medical Device

Establishes special controls for a new orthopedic device category, providing regulatory clarity while balancing safety and access. The FDA has classified the wearable vibration device for orthopedic use as a Class II medical device, subject to special controls.

Notable CMS 💬 Comments close in 4 days (Nov 16)

CMS Seeks Emergency OMB Clearance to Expand Home Health Review Choice Demo to California

CMS requests emergency approval to expand fraud-prevention data collection for home health services in California, with public comments due November 16, 2026. The Centers for Medicare & Medicaid Services (CMS) is seeking emergency clearance from the Office of Management and Budget (OMB) to revise...